These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 31483918)
1. Tyrosine kinase Eph receptor A6 sensitizes glioma-initiating cells towards bone morphogenetic protein-induced apoptosis. Raja E; Morikawa M; Nishida J; Tanabe R; Takahashi K; Seeherman HJ; Saito N; Todo T; Miyazono K Cancer Sci; 2019 Nov; 110(11):3486-3496. PubMed ID: 31483918 [TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic protein signaling mediated by ALK-2 and DLX2 regulates apoptosis in glioma-initiating cells. Raja E; Komuro A; Tanabe R; Sakai S; Ino Y; Saito N; Todo T; Morikawa M; Aburatani H; Koinuma D; Iwata C; Miyazono K Oncogene; 2017 Aug; 36(35):4963-4974. PubMed ID: 28459464 [TBL] [Abstract][Full Text] [Related]
3. miR-656 inhibits glioma tumorigenesis through repression of BMPR1A. Guo M; Jiang Z; Zhang X; Lu D; Ha AD; Sun J; Du W; Wu Z; Hu L; Khadarian K; Shen J; Lin Z Carcinogenesis; 2014 Aug; 35(8):1698-706. PubMed ID: 24480809 [TBL] [Abstract][Full Text] [Related]
4. Bone morphogenetic proteins. Chen D; Zhao M; Mundy GR Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726 [TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic protein-2 and -4 play tumor suppressive roles in human diffuse-type gastric carcinoma. Shirai YT; Ehata S; Yashiro M; Yanagihara K; Hirakawa K; Miyazono K Am J Pathol; 2011 Dec; 179(6):2920-30. PubMed ID: 21996676 [TBL] [Abstract][Full Text] [Related]
6. Paired related homeobox 1 transactivates dopamine D2 receptor to maintain propagation and tumorigenicity of glioma-initiating cells. Li Y; Wang W; Wang F; Wu Q; Li W; Zhong X; Tian K; Zeng T; Gao L; Liu Y; Li S; Jiang X; Du G; Zhou Y J Mol Cell Biol; 2017 Aug; 9(4):302-314. PubMed ID: 28486630 [TBL] [Abstract][Full Text] [Related]
7. BMP type I receptor ALK2 is required for angiotensin II-induced cardiac hypertrophy. Shahid M; Spagnolli E; Ernande L; Thoonen R; Kolodziej SA; Leyton PA; Cheng J; Tainsh RE; Mayeur C; Rhee DK; Wu MX; Scherrer-Crosbie M; Buys ES; Zapol WM; Bloch KD; Bloch DB Am J Physiol Heart Circ Physiol; 2016 Apr; 310(8):H984-94. PubMed ID: 26873969 [TBL] [Abstract][Full Text] [Related]
8. Over-expression of BMPR-IB reduces the malignancy of glioblastoma cells by upregulation of p21 and p27Kip1. Liu S; Yin F; Fan W; Wang S; Guo XR; Zhang JN; Tian ZM; Fan M J Exp Clin Cancer Res; 2012 May; 31(1):52. PubMed ID: 22650359 [TBL] [Abstract][Full Text] [Related]
9. ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the BMP type I receptor and sensitizes mesenchymal cells to BMP-induced osteoblast differentiation and bone formation. van Dinther M; Visser N; de Gorter DJ; Doorn J; Goumans MJ; de Boer J; ten Dijke P J Bone Miner Res; 2010 Jun; 25(6):1208-15. PubMed ID: 19929436 [TBL] [Abstract][Full Text] [Related]
11. Basal expression of bone morphogenetic protein receptor is reduced in mild asthma. Kariyawasam HH; Xanthou G; Barkans J; Aizen M; Kay AB; Robinson DS Am J Respir Crit Care Med; 2008 May; 177(10):1074-81. PubMed ID: 18292470 [TBL] [Abstract][Full Text] [Related]
12. Role of bone morphogenetic proteins in sprouting angiogenesis: differential BMP receptor-dependent signaling pathways balance stalk Benn A; Hiepen C; Osterland M; Schütte C; Zwijsen A; Knaus P FASEB J; 2017 Nov; 31(11):4720-4733. PubMed ID: 28733457 [TBL] [Abstract][Full Text] [Related]
13. Snail depletes the tumorigenic potential of glioblastoma. Savary K; Caglayan D; Caja L; Tzavlaki K; Bin Nayeem S; Bergström T; Jiang Y; Uhrbom L; Forsberg-Nilsson K; Westermark B; Heldin CH; Ferletta M; Moustakas A Oncogene; 2013 Nov; 32(47):5409-20. PubMed ID: 23524585 [TBL] [Abstract][Full Text] [Related]
14. Fstl1 Promotes Glioma Growth Through the BMP4/Smad1/5/8 Signaling Pathway. Jin X; Nie E; Zhou X; Zeng A; Yu T; Zhi T; Jiang K; Wang Y; Zhang J; You Y Cell Physiol Biochem; 2017; 44(4):1616-1628. PubMed ID: 29212066 [TBL] [Abstract][Full Text] [Related]
15. Role of glycosyltransferase PomGnT1 in glioblastoma progression. Lan J; Guo P; Lin Y; Mao Q; Guo L; Ge J; Li X; Jiang J; Lin X; Qiu Y Neuro Oncol; 2015 Feb; 17(2):211-22. PubMed ID: 25085363 [TBL] [Abstract][Full Text] [Related]
16. Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastoma. Hasan T; Caragher SP; Shireman JM; Park CH; Atashi F; Baisiwala S; Lee G; Guo D; Wang JY; Dey M; Wu M; Lesniak MS; Horbinski CM; James CD; Ahmed AU Cell Death Dis; 2019 Mar; 10(4):292. PubMed ID: 30926789 [TBL] [Abstract][Full Text] [Related]
18. EphA6 promotes angiogenesis and prostate cancer metastasis and is associated with human prostate cancer progression. Li S; Ma Y; Xie C; Wu Z; Kang Z; Fang Z; Su B; Guan M Oncotarget; 2015 Sep; 6(26):22587-97. PubMed ID: 26041887 [TBL] [Abstract][Full Text] [Related]
19. Bone morphogenetic protein signaling promotes tumorigenesis in a murine model of high-grade glioma. Hover LD; Owens P; Munden AL; Wang J; Chambless LB; Hopkins CR; Hong CC; Moses HL; Abel TW Neuro Oncol; 2016 Jul; 18(7):928-38. PubMed ID: 26683138 [TBL] [Abstract][Full Text] [Related]
20. A novel bone morphogenetic protein signaling in heterotypic cell interactions in prostate cancer. Yang S; Pham LK; Liao CP; Frenkel B; Reddi AH; Roy-Burman P Cancer Res; 2008 Jan; 68(1):198-205. PubMed ID: 18172312 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]